Made by SterisWHO-GMP

Pafagold 10

by Steris Healthcare Pvt. Ltd.

Be the first to review

Dapagliflozin 10 mg

PAFAGOLD 10 Tablets by Steris Healthcare contain Dapagliflozin 10 mg, an oral antidiabetic medicine belonging to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class. It helps lower blood glucose levels by increasing the elimination of excess glucose through urine. Dapagliflozin may also be prescribed for certain eligible patients with heart failure or chronic kidney disease, depending on the approved indications. Use PAFAGOLD 10 only as prescribed by a qualified healthcare professional.

View medicine information ↓
Choose a pack
₹88.59₹126.5630% offinclusive of all taxes
Subscribe & save 5%Refill on your schedule · skip or cancel anytimeSave ₹4.43 every delivery
Set up autopay

Delivery estimate appears here

ManufacturerSteris Healthcare Pvt. Ltd.
Manufacturing qualityWHO-GMP verified
Expiry policyMinimum 3 months
ReviewedClinical review pending

Medicine information

Uses & overview

PAFAGOLD 10 is an oral medicine from Steris Healthcare containing Dapagliflozin 10 mg per tablet. Dapagliflozin belongs to the SGLT2 inhibitor class and works by reducing the reabsorption of glucose in the kidneys. This allows excess glucose to be removed through urine and helps support blood glucose management. Product Details Brand Name: PAFAGOLD 10 Composition: Dapagliflozin 10 mg Dosage Form: Tablets Therapeutic Category: Oral Antidiabetic Medicine Drug Class: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Company Name: Steris Healthcare How PAFAGOLD 10 Works Dapagliflozin inhibits the SGLT2 protein in the kidneys, which is responsible for reabsorbing a substantial portion of filtered glucose back into the bloodstream. By reducing this reabsorption, it increases urinary glucose excretion and helps lower blood glucose levels. Uses of PAFAGOLD 10 Tablets Depending on the approved product label and the patient's medical condition, dapagliflozin may be prescribed for: Type 2 diabetes mellitus: Helps improve blood glucose control alongside diet, physical activity, and an appropriate diabetes management plan. Heart failure: May reduce the risk of worsening heart failure and related hospitalisation in eligible patients. Chronic kidney disease: May help reduce the risk of disease progression and related complications in eligible patients. The appropriate indication depends on the patient's diagnosis, kidney function, medical history, and applicable prescribing guidelines. Dapagliflozin is not a substitute for insulin in patients who require insulin therapy and is not used to treat type 1 diabetes as a routine glucose-lowering medicine.

How to use

Take PAFAGOLD 10 Tablets exactly as prescribed by your doctor. Dapagliflozin is generally taken once daily, with or without food, but you should follow your individual prescription and the approved product leaflet. Swallow the tablet with water. Maintain adequate hydration and monitor your blood glucose as recommended by your healthcare professional. Do not change the dose or stop treatment without medical advice. Inform your doctor if you develop vomiting, diarrhoea, dehydration, or a serious illness. Ask your healthcare professional whether treatment should be temporarily withheld before surgery, during prolonged fasting, or during an acute illness, as these situations may increase the risk of diabetic ketoacidosis.

Storage

Store PAFAGOLD 10 Tablets according to the instructions printed on the product packaging. Keep the tablets in their original packaging and protect them from excessive heat and moisture. Keep the medicine out of reach of children. Do not use the tablets after their expiry date or if the packaging is damaged.

Important guidance

Safety advice

Check with your doctor
AlcoholConsult your doctor

Excessive alcohol consumption may increase the risk of dehydration and ketoacidosis in susceptible patients.

PregnancyConsult your doctor

Dapagliflozin is generally not recommended during the second and third trimesters. Seek medical advice if pregnant or planning pregnancy.

BreastfeedingConsult your doctor

Dapagliflozin is generally not recommended during breastfeeding. Discuss suitable alternatives with your doctor.

DrivingConsult your doctor

Low blood sugar may affect driving, particularly when dapagliflozin is combined with insulin or sulfonylureas.

KidneyConsult your doctor

Kidney function should be assessed before treatment. Suitability depends on the indication and the patient's kidney function.

LiverConsult your doctor

Inform your doctor about liver disease before starting treatment.

Clinical review pending

This page uses verified catalogue facts and responsible medicine-information rules. It supports awareness and does not replace a doctor's advice.

Customer feedback

Ratings & reviews

Be the first to review this product.

Loading reviews…

Write a review

Your feedback helps other customers make informed choices.

0/3000 charactersChecking your sign-in status…

Same-salt substitutes

Frequently viewed together

Rx · H
Gliempaflozin Met Er 25 And 1000 product pack

Gliempaflozin Met Er 25 And 1000

For 10 Tablets

Empagliflozin 25 mg + Metformin Hydrochloride 1000 mg

No reviews
₹161.21₹230.3030% off
Prescription required before dispatch
Rx · H
Linaliglip Empamet product pack

Linaliglip Empamet

For 15 Tablets

Empagliflozin 25 mg + Linagliptin 5 mg + Metformin 1000 mg

No reviews
₹154.00₹220.0030% off
Prescription required before dispatch
Rx · H
Acarbzone M 500 product pack

Acarbzone M 500

For 10 Tablet

Acarbose 50 mg + Metformin 500 mg

No reviews
₹108.22₹154.6030% off
Prescription required before dispatch
Rx · H
Acarbzone 25 product pack

Acarbzone 25

For 10 Tablet

Acarbose 25 mg

No reviews
₹52.83₹75.4730% off
Prescription required before dispatch

Let’s help you order

Speak to our team about medicine availability, prescriptions or your order.

Opens your device’s calling app.